K Number
K172143
Device Name
uMI 780 PET/CT System
Date Cleared
2018-04-13

(270 days)

Product Code
Regulation Number
892.1200
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The uMI 780 PET/CT is a diagnostic imaging system that combines two existing imaging modalities -PET and CT. The quantitative distribution information of PET radiopharmaceuticals within the patient body measured by PET can assist healthcare providers in assessing the metabolic and physiological functions. CT provides diagnostic tomographic anatomical information as well as photon attenuation information for the scanned region. The accurate registration of PET and CT images provides anatomical reference for the findings in the PET images. This system is intended to be operated by qualified healthcare professionals to assist in the detection, localization, diagnosis, staging, treatment planning and treatment response evaluation for diseases and disorders in, but not limit to, oncology, cardiology and neurology.
Device Description
The uMI 780 PET/CT system is a combined multi-slice X-Ray Computed Tomography and Positron Emission Tomography scanner. This system is intended to be operated by qualified healthcare professionals for performing diagnostic imaging examinations. The spatial alignment and precise image registration between PET and CT ensure the PET and CT images of the same region can be fused accurately for reading. PET measures the distribution of PET radiopharmaceuticals inside the human body quantitatively. CT produces the anatomical information of the same scanned region, and provides accurate localization for the findings in the PET images. The attenuation information contained in the CT images can be utilized in the PET image reconstruction to ensure quantitation accuracy. The PET system has time-of-flight capability with a timing resolution of 520ps. It has a 300mm-long axial field of view (FoV) and a system sensitivity higher than 15cps/kBq. The uMI 780 PET/CT system also includes a patient table, a workstation with associated software installed. The software is used for patient management, data management, scan control, image reconstruction and image reading. All patient images produced by the system conform to the DICOM 3.0 standard.
More Information

Not Found

No
The summary describes a standard PET/CT imaging system and its components, focusing on hardware specifications, image reconstruction, and image fusion. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies.

No
This device is described as a "diagnostic imaging system" intended to assist in "detection, localization, diagnosis, staging, treatment planning and treatment response evaluation," rather than directly providing therapy.

Yes

The "Intended Use / Indications for Use" section explicitly states that the system is intended to "assist in the detection, localization, diagnosis, staging, treatment planning and treatment response evaluation for diseases and disorders". The "Device Description" also mentions its use for "performing diagnostic imaging examinations".

No

The device description explicitly states it is a combined multi-slice X-Ray Computed Tomography and Positron Emission Tomography scanner, which are hardware components. While it includes software for various functions, it is not solely software.

Based on the provided text, the uMI 780 PET/CT device is not an In Vitro Diagnostic (IVD).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices intended to be used in vitro for the examination of specimens, including blood, tissue, and urine, derived from the human body, solely or principally for the purpose of providing information concerning a physiological state, state of health, or disease or congenital abnormality.
  • Device Function: The uMI 780 PET/CT is an in vivo imaging system. It directly scans the patient's body using PET and CT technologies to produce images. It does not analyze specimens outside the body.
  • Intended Use: The intended use clearly states it's a "diagnostic imaging system" used to "assist healthcare providers in assessing the metabolic and physiological functions" and "assist in the detection, localization, diagnosis, staging, treatment planning and treatment response evaluation for diseases and disorders". This is consistent with an in vivo imaging device.

Therefore, the uMI 780 PET/CT falls under the category of medical imaging devices, not In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

The uMI 780 PET/CT is a diagnostic imaging system that combines two existing imaging modalities -PET and CT. The quantitative distribution information of PET radiopharmaceuticals within the patient body measured by PET can assist healthcare providers in assessing the metabolic and physiological functions. CT provides diagnostic tomographic anatomical information as well as photon attenuation information for the scanned region. The accurate registration of PET and CT images provides anatomical reference for the findings in the PET images.

This system is intended to be operated by qualified healthcare professionals to assist in the detection, localization, diagnosis, staging, treatment planning and treatment response evaluation for diseases and disorders in, but not limit to, oncology, cardiology and neurology.

Product codes (comma separated list FDA assigned to the subject device)

KPS, JAK

Device Description

The uMI 780 PET/CT system is a combined multi-slice X-Ray Computed Tomography and Positron Emission Tomography scanner. This system is intended to be operated by qualified healthcare professionals for performing diagnostic imaging examinations. The spatial alignment and precise image registration between PET and CT ensure the PET and CT images of the same region can be fused accurately for reading. PET measures the distribution of PET radiopharmaceuticals inside the human body quantitatively. CT produces the anatomical information of the same scanned region, and provides accurate localization for the findings in the PET images. The attenuation information contained in the CT images can be utilized in the PET image reconstruction to ensure quantitation accuracy. The PET system has time-of-flight capability with a timing resolution of 520ps. It has a 300mm-long axial field of view (FoV) and a system sensitivity higher than 15cps/kBq.

The uMI 780 PET/CT system also includes a patient table, a workstation with associated software installed. The software is used for patient management, data management, scan control, image reconstruction and image reading. All patient images produced by the system conform to the DICOM 3.0 standard.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

PET, CT

Anatomical Site

patient body

Indicated Patient Age Range

Not Found

Intended User / Care Setting

qualified healthcare professionals

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with standards. Performance testing in accordance with NEMA NU2:2012 was conducted and met the predetermined acceptance values. No clinical study is included in this submission.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Sensitivity: >/=15cps/kBq
NECR Peak Value: >/=165kcps@16kBq/cc
Peak True Count Rate: >/=500kcps@30kBq/cc
PET Scatter Fraction:

§ 892.1200 Emission computed tomography system.

(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Shanghai United Imaging Healthcare Co., Ltd. % Shumei Wang QM&RA VP NO.2258 Chengbei Road,Jiading District Shanghai. 201807 CHINA

Re: K172143

Trade/Device Name: uMI 780 PET/CT System Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: II Product Code: KPS, JAK, Dated: March 10, 2018 Received: March 13, 2018

Dear Shumei Wang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

April 13, 2018

1

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and

Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Michael D'Hara For

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

2

Image /page/2/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized symbol that resembles a shield or crest. The symbol is divided into sections by a white line, creating a modern and abstract design.

Indications for Use

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drup Administration Indications for Use

Form Approved:OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below

510(k) Number( if known)

K172143

Device Name

uMI 780 PET/CT System

Indications for Use (Describe):

The uMI 780 PET/CT is a diagnostic imaging system that combines two existing imaging modalities -PET and CT. The quantitative distribution information of PET radiopharmaceuticals within the patient body measured by PET can assist healthcare providers in assessing the metabolic and physiological functions. CT provides diagnostic tomographic anatomical information as well as photon attenuation information for the scanned region. The accurate registration of PET and CT images provides anatomical reference for the findings in the PET images.

This system is intended to be operated by qualified healthcare professionals to assist in the detection, localization, diagnosis, staging, treatment planning and treatment response evaluation for diseases and disorders in, but not limit to, oncology, cardiology and neurology.

Type of use:

Precription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (Part 21 CFR 801 Subpart D)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

PSC Publishing Services (301) 443-6740 FF

SECTION 77 - 1 of 1

3

Image /page/3/Picture/1 description: The image contains the logo for United Imaging. The text "UNITED IMAGING" is displayed in bold, sans-serif font. To the right of the text is a stylized logo consisting of a dark gray shield shape with a white vertical line running down the center and a horizontal line intersecting it near the top, forming a stylized "U" shape.

SECTION 16

510(k) Summary

SECTION 16 - Page 1 of 7

4

Image /page/4/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" stacked on top of each other in a bold, sans-serif font. To the right of the words is a stylized "U" shape, which is made up of two vertical lines and a horizontal line in the middle. The logo is simple and modern, and the colors are muted.

510(k) SUMMARY

1. Date of Preparation: March 9, 2018

2. Sponsor Identification

Client Name:Shanghai United Imaging Healthcare Co.,Ltd.
Client Address:NO.2258 Chengbei Road, Jiading District, Shanghai,China
Establishment
Registration Number:Not yet registered
Contact Person:Wang Shumei
Position:QM&RA VP
Tel:+86-21-67076888-6776
Fax:+86-21-67076889
Email:shumei.wang@united-imaging.com

3. Identification of Proposed Device

Model(s):uMI 780
Trade Name:uMI 780
Common Name:Positron Emission Tomography and
Computed Tomography System
Classification Name:Emission Computed Tomography System per 21 CFR 892.1200
Computed Tomography X-Ray System per 21 CFR 892.1750
Regulation Number:21 CFR 892.1200
Product Code:KPS and JAK
Review Panel:Radiology
Classification:Class II

5

Image /page/5/Picture/1 description: The image contains the logo for United Imaging. The words "UNITED" and "IMAGING" are stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized "U" symbol, which is also in a bold, sans-serif font. The logo is simple and modern, and the use of a bold font gives it a strong and confident look.

Proposed Device Description 4.

The uMI 780 PET/CT system is a combined multi-slice X-Ray Computed Tomography and Positron Emission Tomography scanner. This system is intended to be operated by qualified healthcare professionals for performing diagnostic imaging examinations. The spatial alignment and precise image registration between PET and CT ensure the PET and CT images of the same region can be fused accurately for reading. PET measures the distribution of PET radiopharmaceuticals inside the human body quantitatively. CT produces the anatomical information of the same scanned region, and provides accurate localization for the findings in the PET images. The attenuation information contained in the CT images can be utilized in the PET image reconstruction to ensure quantitation accuracy. The PET system has time-of-flight capability with a timing resolution of 520ps. It has a 300mm-long axial field of view (FoV) and a system sensitivity higher than 15cps/kBq.

The uMI 780 PET/CT system also includes a patient table, a workstation with associated software installed. The software is used for patient management, data management, scan control, image reconstruction and image reading. All patient images produced by the system conform to the DICOM 3.0 standard.

5. Intended Use Statement of Proposed Device

The uMI 780 PET/CT is a diagnostic imaging system that combines two existing imaging modalities - PET and CT. The quantitative distribution information of PET radiopharmaceuticals within the patient body measured by PET can assist healthcare providers in assessing the metabolic and physiological functions. CT provides diagnostic tomographic anatomical information as well as photon attenuation information for the scanned region. The accurate registration and fusion of PET and CT images provides anatomical reference for the findings in the PET images.

This system is intended to be operated by qualified healthcare professionals to assist in the detection, localization, diagnosis, staging, treatment planning and

SECTION 16 - Page 3 of 7

6

Image /page/6/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized "U" shape, which is formed by two vertical lines and a horizontal line connecting them at the top. The logo is simple and modern, and the use of bold text and a clean design makes it easily recognizable.

treatment response evaluation for diseases and disorders in, but not limit to, oncology, cardiology and neurology.

Identification of Predicate Device(s) 6.

510(k) Number:K151486
Product Name:Positron Emission Tomography (PET) System
Computed Tomography (CT) System
Model Name:Biograph mCT and mCT Flow PET/CT Scanners

7. Non-clinical Test Conclusion

Non clinical tests were conducted to verify that the proposed device met all design specifications as was Substantially Equivalent (SE) to the predicate device. The test results demonstrated that the proposed device complies with the following standards:

  • Recognition Number 19-4:AAMI ANSI ES60601-1: 2005/(R)2012 and A1:2012

  • Recognition Number 12-269:IEC 60601-1-3: Edition 2.1

  • Recognition Number 12-257:IEC 60601-2-44: Edition 3.0

  • Recognition Number 19-1:IEC 60601-1-2: Edition 3

  • Recognition Number 12-273:IEC 60825-1:Edition 2.0

  • Recognition Number 12-270:NEMA 61223-3-5: First edition

  • Recognition Number 12-265:NEMA NU 2:2012

  • Recognition Number 2-174:ISO 10993-10:Third Edition

  • Recognition Number 2-245:ISO 10993-5:Third edition

  • Recognition Number 12-225:NEMA XR 25: 2010

  • Recognition Number 12-287:NEMA XR 28:2013

  • NEMA XR 29:2013

8. Clinical Test Conclusion

No clinical study is included in this submission.

SECTION 16 - Page 4 of 7

7

Image /page/7/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the word "UNITED" stacked on top of the word "IMAGING", both in a bold, sans-serif font. To the right of the text is a stylized "U" shape, which is also in a bold font. The color of the logo is a dark gray.

9. Substantial Equivalence Comparison

Table 1 Comparison of Technology Characteristics
--------------------------------------------------------------
ItemProposed Device(s)Predicate Device(s)
Product CodeKPS,JAKKPS,JAK
Regulation No.21 CFR 892.120021 CFR 892.1200
ClassIIII
Intended UseThe uMI 780 PET/CT is a
diagnostic imaging system that
combines two existing imaging
modalities - PET and CT. The
quantitative distribution
information of PET
radiopharmaceuticals within the
patient body measured by PET can
assist healthcare providers in
assessing the metabolic and
physiological functions. CT
provides diagnostic tomographic
anatomical information as well as
photon attenuation information for
the scanned region. The accurate
registration and fusion of PET and
CT images provides anatomical
reference for the findings in the
PET images.
This system is intended to be
operated by qualified healthcare
professionals to assist in the
detection, localization, diagnosis,
staging, restaging, treatment
planning and treatment response
evaluation for diseases and
disorders in, but not limit to,
oncology, cardiology and
neurology.The Siemens Biograph mCT systems
are combined X-Ray Computed
Tomography (CT) and Positron
Emission
Tomography (PET) scanners that
provide registration and fusion of
high resolution physiologic and
anatomic information.
The CT component produces cross-
sectional images of the body by
computer reconstruction of X-Ray
transmission data from either the
same axial plane taken at different
angles or spiral planes taken at
different angles. The PET subsystem
images and measures the distribution
of PET radiopharmaceuticals in
humans for the purpose of
determining various metabolic
(molecular) and physiologic
functions within the human body and
utilizes the CT for fast attenuation
correction maps for PET studies and
precise anatomical reference for the
fused PET and CT images.
The system maintains independent
functionality of the CT and PET
devices, allowing for single modality
CT and / or PET diagnostic imaging.
These systems are intended to be
utilized by appropriately trained
health care professionals to aid in
detecting, localizing, diagnosing,
staging and restaging of lesions,
tumors, disease and organ function
for the evaluation of diseases and
disorders such as, but not limited to,
cardiovascular disease, neurological
disorders and cancer. The images
produced by the system can also be
used by the physician to aid in
radiotherapy treatment planning and
interventional radiology procedures.
ItemProposed Device(s)Predicate Device(s)
PET Specification
Sensitivity>/=15cps/kBq>/=9.4cps/kBq
NECR Peak Value>/=165kcps@16kBq/cc>/=165 kcps@28kBq/cc
Peak True Count Rate>/=500kcps@30kBq/cc>/=575kcps@40kBq/cc
PET Scatter Fraction=0.44